Lopinavir/Ritonavir
ApprovedCompleted 0 watching 0 views this week🔥 Hot
85
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
HIV Infection
Conditions
HIV Infection
Trial Timeline
Oct 1, 2002 → Jan 1, 2008
NCT ID
NCT00234975About Lopinavir/Ritonavir
Lopinavir/Ritonavir is a approved stage product being developed by AbbVie for HIV Infection. The current trial status is completed. This product is registered under clinical trial identifier NCT00234975. Target conditions include HIV Infection.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00648999 | Approved | Completed |
| NCT00234975 | Approved | Completed |
Competing Products
20 competing products in HIV Infection